Skip to Main Content

Paper Details

Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D.
JAMA Intern Med
2
2021
Author NameAffiliation
Stacie B DusetzinaVanderbilt University School of Medicine
Stacie B DusetzinaVanderbilt-Ingram Cancer Center
Ameet SarpatwariDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
  • 1 - 3

Datasets

Release 1.2